LULU Q1 2026 Earnings EPS Surprise Shows Resilience Amid Tepid Market Response
Passage Bio Q1 2026 Earnings Narrowerthanexpected loss signals disciplined spending
Arthur J Gallagher Co AJG Q1 2026 Earnings Modest EPS Miss Masks Steady Operational Progress
VLYPO Q1 2026 Earnings EPS Beats Estimates by 507 Amid Steady Performance
CRISPR Therapeutics Q1 2026 Earnings Slight EPS Miss as Clinical Pipeline Progresses
HCTI Q4 2025 Earnings Staggering EPS Miss Driven by Deepening Losses